The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement: Multicenter, Prospective, Open-label, Observational Study
Phase of Trial: Phase IV
Latest Information Update: 20 Nov 2013
Price : $35 *
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Janssen
- 23 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Mar 2013 Planned end date changed from 1 Apr 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.